Small study hints anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients By Brenda Goodman , CNN 11 minute read ...

GE HealthCare (GEHC) announced that the U.S. Food and Drug Administration has approved an updated label for its positron emission tomography or PET imaging agent Vizamyl (flutemetamol F 18 injection) ...

The revised label expands the brain-scan agent's use, and means that Vizamyl can now be used to diagnose Alzheimer's and predict the development of dementia due to disease, the company said. The ...

In conclusion, anti–amyloid-beta MAB therapy is becoming more prevalent in managing early-stage dementia in AD. Therefore, early detection is key to identifying patients who would potentially ...

Moving Beyond Anti-amyloid Therapy for the Prevention and Treatment of Alzheimer's Disease. Michael A Castello; John David Jeppson; Salvador Soriano. Disclosures. BMC Neurol. 2014;14(169) ...

Small study hints anti-amyloid therapy may keep Alzheimer’s symptoms at ... The researchers have been testing amyloid-removing therapies in a group of people who have rare genetic mutations that ...

Voyager Therapeutics presents data on tau silencing therapy VY1706 and anti-amyloid therapy at ASGCT 2025. Quiver AI Summary. Voyager Therapeutics, Inc. has announced that it will present eight ...

Anti-Amyloid Therapy – Will Depleters Change the Game? Presenter: Scott Solomon. February 11, 2025. REGISTER for free or LOG IN to view this content. Heart Failure. THT 2025. Up Next. Presentation THT ...